AbbVie signals major oncology momentum at ASCO
With standout ADC and t-cell engager response data across hard-to-treat cancers
With standout ADC and t-cell engager response data across hard-to-treat cancers
Access to genomic testing, not therapy cost, is the biggest challenge
The initiative by Rheumatology Association of Gujarat is aimed at strengthening patient-centric autoimmune care
Highlighting KEYTRUDA & expanding cancer pipeline
The proposed biosimilar to Keytruda demonstrated pharmacokinetic bioequivalence in a multicountry Phase 1 study involving non-small cell lung cancer patients
Appointment strengthens Medanta’s pediatric super-specialty and respiratory care services in the Delhi-NCR region.
Doctors highlight rising respiratory risks linked to pollution, seasonal changes, and poor treatment adherence amid increasing asthma burden in India
Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses
Notice of Compliance from Health Canada enables marketing authorisation for cancer biosimilar in Canadian market
Subscribe To Our Newsletter & Stay Updated